M. Burnier

Discipline

Anthropologie biologique (19) Psychologie (13) Sociologie (7) Economies et finances (4) Linguistique (3) Sciences de l'information et de la communication (3) Gestion et management (3) Histoire, Philosophie et Sociologie des sciences (2) Science politique (1) Géographie (1) Anthropologie sociale et ethnologie (1)

Type de document

Articles (191) Recensions (48) Colloques et conférences (2) Livres et chapitres d'ouvrages (1)

Co-auteur

Date

Source

Mot-clé

Human beings (110) Patients (97) Patients (95) Hypertension (93) Treatment (82) Blood pressure (77) Therapeutics (60) thérapie (58) risque (56) Risk (56) maladie (52) maladie (52) Methods (51) Methods (51) Management (48) Control (47) Population (46) Population (45) Use (45) Blood (42) âge (40) Age (40) Age (40) effet (38) Older people (37) Swiss (36) gestion (33) adulte (33) Management (33) adulte (33)

Documents écrit par M. Burnier (194) | parle de M. Burnier (0)

Highlights of the 2023 European Society of Hypertension Guidelines: what has changed in the management of hypertension in patients with cardiac diseases?
S.E. Kjeldsen et al.
Lowering of systolic blood pressure in hypertensive patients: insights and questions from the ESPRIT study.
R. Kreutz et al.
Poor Physician Adherence to Clinical Guidelines in Hypertension-Time for Physicians to Face Clinical Inertia.
M. Burnier (1 août 2024)
2024 European Society of Hypertension clinical practice guidelines for the management of arterial hypertension.
R. Kreutz et al.
Physician and patient adherence in hypertension trials: a point of view on an important issue to resolve.
M. Burnier
A European Renal Association (ERA) synopsis for nephrology practice of the 2023 European Society of Hypertension (ESH) Guidelines for the Management of Arterial Hypertension.
P. Sarafidis et al. (31 mai 2024)
Rationale for the Inclusion of β-Blockers Among Major Antihypertensive Drugs in the 2023 European Society of Hypertension Guidelines.
G. Mancia et al.
A new, deep learning-based method for the analysis of autopsy kidney samples used to study sex differences in glomerular density and size in a forensic population.
V. Vilmont et al.
Medical Measures in Hypertensives Considered Resistant.
FEM Fadl Elmula et al. (15 avr. 2024)
Rationale of treatment recommendations in the 2023 ESH hypertension guidelines.
G. Mancia et al.
The current best drug treatment for hypertensive heart failure with preserved ejection fraction.
A. Rist et al.
What Is the Current Best Drug Treatment for Hypertensive Heart Failure With Preserved Ejection Fraction? Review of the Totality of Evidence.
K. Sevre et al. (1 janv. 2024)
The differential impact of a 6-versus 12-month pharmacist-led interprofessional medication adherence program on medication adherence in patients with diabetic kidney disease: the randomized PANDIA-IRIS study.
C. Bandiera et al. (2024)
Optimizing drug adherence in hypertension: More than a mind game.
T. Robberechts et al. (2024)
The role of adherence in patients with chronic diseases.
M. Burnier
TIME to face the reality about evening dosing of antihypertensive drugs in hypertension.
S.E. Kjeldsen et al.
Cardiovascular complications in chronic kidney disease: a review from the European Renal and Cardiovascular Medicine Working Group of the European Renal Association.
C. Zoccali et al. (5 sept. 2023)
How to optimize the use of diuretics in patients with heart failure?
M. Burnier et al.
Determinants of Renal Micro-Perfusion as Assessed with Contrast-Enhanced Ultrasound in Healthy Males and Females.
A. Ulpiano Trillig et al. (20 juin 2023)
Single-Pill Combination with Three Antihypertensive Agents to Improve Blood Pressure Control in Hypertension: Focus on Olmesartan-Based Combinations.
M. Burnier et al.
Renal Denervation: A Practical Guide for Health Professionals Managing Hypertension.
R. Schmieder et al. (2023)
Gout and hyperuricaemia: modifiable cardiovascular risk factors?
M. Burnier (2023)
The impact of war on the development and progression of arterial hypertension and cardiovascular disease: protocol of a prospective study among Ukrainian female refugees.
A. Shalimova et al. (2023)
Blood pressure and vascular determinants of glomerular filtration rate decline in diabetic kidney disease.
L. Trucello et al. (2023)
A 30th anniversary and a glimpse of the future.
M. Burnier et al.

next